SEC Tracker
Get the app
LFVN · XBRL financial data

Lifevantage financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (LFVN's year ends in late June)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers51,36451,62448,24548,931*47,21467,76258,44055,114*47,56148,93143,71642,377*
Cost of goods and services sold10,18011,06610,17210,022*9,49113,19511,11311,065*9,74512,7229,1729,334*
Gross profit41,18440,55838,07338,909*37,72354,56747,32744,049*37,81636,20934,54433,043*
Research and development200100200200*300200400400*300200200200*
Selling, general and administrative17,96220,06516,42514,020*14,84818,61417,06618,679*14,85315,82713,86513,873*
Total operating expenses40,43541,81936,13935,999*35,15351,13943,27441,901*35,54835,72232,86631,376*
Operating income (loss)749(1,261)1,9342,910*2,5703,4284,0532,148*2,2684871,6781,667*
Interest expense———year only————————
Other income (expense)(88)41(89)(277)*(51)(469)(4)137*(114)(34)(46)(4)*
Income tax expense (benefit)200(456)2621,406*752539710437*86197294417*
Net income (loss)629(656)1,6591,305*1,8262,5503,4701,959*2,1552761,3621,279*
Earnings per share, basic USD per share0.05(0.05)0.130.11*0.150.210.280.16*0.170.020.110.10*
Earnings per share, diluted USD per share0.05(0.05)0.130.10*0.140.190.260.15*0.170.020.110.10*
Weighted average shares, basic thousands of shares12,53712,61212,42412,256*12,16212,21112,35012,284*12,39812,64312,62512,471*
Weighted average shares, diluted thousands of shares13,10912,61212,98613,240*12,82413,17713,30012,650*12,94612,74512,66012,453*

Balance sheet

CSV

Fiscal quarters (LFVN's year ends in late June)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents18,40517,33117,37716,88614,59621,59522,46920,20113,09110,18112,48314,920
Accounts receivable2,5042,3352,1352,9492,9682,0873,2403,2942,4252,2562,4202,990
Inventory15,70614,97215,16215,05516,91417,46722,22120,66920,59418,97818,38216,167
Prepaid and other current assets5,1373,7892,7632,4433,4514,6416,1846,0953,6404,4163,8292,834
Total current assets41,90138,66137,79737,64638,81545,79054,11450,89445,04838,55739,31438,297
Property and equipment, net9,3108,9708,3497,8137,4777,1366,7306,2075,9976,4266,8507,310
Right-of-use asset9,8019,5269,3829,5699,4098,9158,6078,0417,6647,2746,9086,715
Goodwill———————0—472472465
Total assets66,60462,68261,30760,29961,46068,52777,23771,95861,57961,16962,12762,111
Accounts payable6,7636,2376,9545,8535,2705,7577,0384,6004,3564,8915,1475,156
Accrued liabilities———7,874———13,513———7,412
Total current liabilities24,69923,01722,47522,30922,07227,54932,58327,21718,82919,01320,10120,227
Lease liability, non-current12,46012,13311,85211,80111,46610,88310,4259,8119,3108,8008,3217,933
Total liabilities37,31035,37534,53834,30833,76338,63843,22637,31728,42228,18228,78828,522
Accumulated deficit(104,005)(106,992)(107,709)(108,738)(108,526)(106,478)(103,511)(104,147)(103,141)(103,441)(103,656)(103,462)
Total stockholders' equity29,29427,30726,76925,99127,69729,88934,01134,64133,15732,98733,33933,589
Total liabilities and equity66,60462,68261,30760,29961,46068,52777,23771,95861,57961,16962,12762,111
Common shares outstanding (cover page) thousands of shares12,71412,86812,70112,47912,52512,55112,58812,69112,70112,79312,61612,527

Cash flows

CSV

Fiscal quarters (LFVN's year ends in late June)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)629(656)1,6591,305*1,8262,5503,4701,959*2,1552761,3621,279*
Stock-based compensation978750*796*756*9171,722*1,521*1,542*826553*704*263*
Depreciation and amortization918962*895*806*797806*803*750*610752*714*697*
Net cash from operating activities4,7651,757*3,093*2,582*(583)9,199*2,228*1,034*(2,305)2,791*4,988*4,767*
Purchases of property and equipment1,133543*291*278*349492*331*199*4391,084*1,011*1,037*
Net cash from investing activities(1,133)(543)*(291)*(278)*(345)(492)*(331)*(199)*(439)(4,827)*(1,011)*(1,037)*
Share repurchases7951,9001,9001,831*1,114002,033*578(1)*1,006*460*
Dividends paid5,534455*448*503*500502*503*562*571575*573*625*
Net cash from financing activities(6,668)(2,544)*(2,464)*(2,741)*(1,828)(1,400)*(1,127)*(3,243)*(4,297)(738)*(1,598)*(1,150)*
Net change in cash(3,200)(1,074)*46*(491)*(2,290)6,999*874*(2,268)*(7,110)(2,910)*2,302*2,437*

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Lifevantage14,92042,377*4,767*12.5M— 10-KJun 30, 2026
Veru23,880not reported(5,467)*17.1M4.4 quarters 10-QJun 30, 2026
Whitehawk Therapeutics85,2340(14,529)*57.0M13.1 quarters 10-QJun 30, 2026
Medicinova25,416458(1,920)*49.2M13.2 quarters 10-QJun 30, 2026
PDS Biotechnology5,596not reported(2,793)*56.0M2.0 quarters 10-QJun 30, 2026
Sutro Biopharma54,3359,839(38,290)*16.6M4.3 quarters 10-QJun 30, 2026
Corbus Pharmaceuticals Holdings23,370not reported(29,626)*19.3M4.0 quarters 10-QJun 30, 2026
iBio56,3950*(6,228)*64.3M14.1 quarters 10-KJun 30, 2026
Seres Therapeutics15,594736(22,394)*9.9M0.7 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.